Toward that goal, we are currently conducting preclinical studies using GRK5-IN-2 to see if we can replicate our cell results in a mouse model of diet-induced obesity and to determine whether GRK5 inhibition could be a valuable translation target. Here, GRK5 is linked to Obesity.